LABTVSNIVF• 6 Months (Normalized)
LABT vs NIVF (Lakewood-Amedex Biotherapeutics Inc. vs NewGenIvf Group Limited)
Showing Closing Date Range from Mar 29 to Sep 25, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
LABT Performance $1.78
-97.94%
Lakewood-Amedex Biotherapeutics Inc.
Normalized Baseline0.00%
NIVF Performance $0.59
-96.64%
NewGenIvf Group Limited
Normalized Baseline0.00%
Alpha Spread Margin NIVF LEADS
-1.3 pts
NIVF outperforming by 1.30 percentage points
LABTNIVF
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
LABT NIVF
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(123 dates)
| Date | LABT Price | LABT Gain (%) | NIVF Price | NIVF Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 23, 2026 | $1.78 | -97.94% | $0.59 | -96.64% | -1.30% |
| Sep 22, 2026 | $1.99 | -97.70% | $0.73 | -95.82% | -1.88% |
| Sep 21, 2026 | $2.05 | -97.63% | $0.72 | -95.90% | -1.73% |
| Sep 18, 2026 | $1.99 | -97.70% | $0.72 | -95.90% | -1.80% |
| Sep 17, 2026 | $1.86 | -97.85% | $0.72 | -95.93% | -1.92% |
| Sep 16, 2026 | $2.09 | -97.58% | $0.79 | -95.53% | -2.05% |
| Sep 15, 2026 | $2.17 | -97.49% | $0.84 | -95.21% | -2.28% |
| Sep 14, 2026 | $2.12 | -97.55% | $0.93 | -94.71% | -2.84% |
| Sep 11, 2026 | $2.22 | -97.43% | $1.06 | -93.96% | -3.47% |
| Sep 10, 2026 | $2.05 | -97.63% | $1.11 | -93.68% | -3.95% |
| Sep 09, 2026 | $2.32 | -97.32% | $1.10 | -93.73% | -3.59% |
| Sep 08, 2026 | $2.18 | -97.48% | $1.11 | -93.68% | -3.80% |
| Sep 04, 2026 | $1.88 | -97.83% | $1.14 | -93.50% | -4.33% |
| Sep 03, 2026 | $1.90 | -97.80% | $1.18 | -93.28% | -4.52% |
| Sep 02, 2026 | $2.07 | -97.61% | $1.21 | -93.11% | -4.50% |
Page 1 of 9